[
  {
    "ts": "2026-02-13T09:32:17+00:00",
    "headline": "Analysis-China biotech licensing boom to hit record in 2026 as pipeline swells",
    "summary": "By Kane Wu and Andrew Silver HONG KONG/SHANGHAI, Feb 13 (Reuters) - Global drugmakers are stepping up their search for China‑developed experimental medicines as they cut costs ahead of patent",
    "url": "https://finance.yahoo.com/news/analysis-china-biotech-licensing-boom-092338804.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "c3513fec-0fd0-35e5-a4af-ce21f8298993",
      "content": {
        "id": "c3513fec-0fd0-35e5-a4af-ce21f8298993",
        "contentType": "STORY",
        "title": "Analysis-China biotech licensing boom to hit record in 2026 as pipeline swells",
        "description": "",
        "summary": "By Kane Wu and Andrew Silver HONG KONG/SHANGHAI, Feb 13 (Reuters) - Global drugmakers are stepping up their search for China‑developed experimental medicines as they cut costs ahead of patent",
        "pubDate": "2026-02-13T09:32:17Z",
        "displayTime": "2026-02-13T09:32:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/ac6bc36f2eeea0b87ca80119317f477d",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "A sign marks the Novartis Institutes for BioMedical Research facility in Cambridge, Massachusetts, U.S., June 16, 2021.   REUTERS/Brian Snyder",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wNkas3Ojb6L_Qs0iS1Bl0Q--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/ac6bc36f2eeea0b87ca80119317f477d.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/e9O53XCBrj9YyJo3Jm9Tzg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/ac6bc36f2eeea0b87ca80119317f477d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/analysis-china-biotech-licensing-boom-092338804.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analysis-china-biotech-licensing-boom-092338804.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVS"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]